Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
36
CNS Quote, Financials, Valuation and Earnings
Last price:
$66.11
Seasonality move
:
5.22%
Day range:
$64.14 - $66.11
52-week range:
$58.39 - $88.77
Dividend yield:
3.83%
P/E ratio:
21.77x
P/S ratio:
6.02x
P/B ratio:
6.01x
Volume:
333.9K
Avg. volume:
339.1K
1-year change:
-24.8%
Market cap:
$3.3B
Revenue:
$564.8M
EPS (TTM):
$2.98
Analysts' Opinion
-
Consensus RatingCohen & Steers, Inc. (New York) has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $72.00, Cohen & Steers, Inc. (New York) has an estimated upside of 11.06% from its current price of $64.83.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $64.00 representing 100% downside risk from its current price of $64.83.
Fair Value
-
According to the consensus of 1 analyst, Cohen & Steers, Inc. (New York) has 11.06% upside to fair value with a price target of $72.00 per share.
CNS vs. S&P 500
-
Over the past 5 trading days, Cohen & Steers, Inc. (New York) has overperformed the S&P 500 by 2.83% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Cohen & Steers, Inc. (New York) does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cohen & Steers, Inc. (New York) has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Cohen & Steers, Inc. (New York) reported revenues of $141.6M.
Earnings Growth
-
Cohen & Steers, Inc. (New York) earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Cohen & Steers, Inc. (New York) reported earnings per share of $0.68.
Enterprise value:
3.4B
EV / Invested capital:
6.01x
Price / LTM sales:
6.02x
EV / EBIT:
18.12x
EV / Revenue:
6.08x
PEG ratio (5yr expected):
50.83x
EV / Free cash flow:
15.16x
Price / Operating cash flow:
16.05x
Enterprise value / EBITDA:
17.11x
Gross Profit (TTM):
$471.4M
Return On Assets:
19.46%
Net Income Margin (TTM):
28.35%
Return On Equity:
27.14%
Return On Invested Capital:
22.73%
Operating Margin:
26.89%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $483.6M | $514.5M | $555.3M | $140.1M | $141.6M | |
| Gross Profit | $410.9M | $444.3M | $471.4M | $121.9M | $113.4M | |
| Operating Income | $168.8M | $187.2M | $186.4M | $45.7M | $38.1M | |
| EBITDA | $187.4M | $200.3M | $197.5M | $48.2M | $40.6M | |
| Diluted EPS | $2.60 | $2.97 | $2.98 | $0.89 | $0.68 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $295.7M | $335M | $339M | $385.8M | -- | |
| Total Assets | $492.7M | $673.4M | $736.6M | $847.1M | -- | |
| Current Liabilities | $136.1M | $119.5M | $112.7M | $110.1M | -- | |
| Total Liabilities | $148.4M | $246.4M | $243.9M | $272.2M | -- | |
| Total Equity | $344.3M | $426.9M | $492.6M | $574.9M | $562M | |
| Total Debt | $12.2M | $127M | $131.2M | $127.1M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $190.4M | $171.6M | $230.2M | $49.4M | $77M | |
| Cash From Investing | -$92.5M | -$126.7M | -$92.1M | -$29.5M | -$42M | |
| Cash From Financing | -$131.8M | -$68.8M | -$153M | -$29.8M | -$32.2M | |
| Free Cash Flow | $143M | $150.7M | $222.8M | $48M | $74.5M | |
CNS
Sector
Market Cap
$3.3B
$522.2M
Price % of 52-Week High
73.04%
92.04%
Dividend Yield
3.83%
1.48%
Shareholder Yield
5.67%
3.02%
1-Year Price Total Return
-24.8%
7.89%
Beta (5-Year)
1.269
0.453
Dividend yield:
3.83%
Annualized payout:
$2.48
Payout ratio:
91.18%
Growth streak:
3 years
Technicals
8-day SMA
Buy
Level
$63.43
200-day SMA
Sell
Level
$70.61
Bollinger Bands (100)
Sell
Level
62.47 - 68.49
Chaikin Money Flow
Buy
Level
282.9K
20-day SMA
Sell
Level
$65.60
Relative Strength Index (RSI14)
Buy
Level
50.03
ADX Line
Buy
Level
35.3
Williams %R
Neutral
Level
-47.6771
50-day SMA
Buy
Level
$64.40
MACD (12, 26)
Buy
Level
17.64
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Neutral
Level
129.6K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (11.8048)
Buy
CA Score
(Annual)
Level (1.1468)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-2.8456)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cohen & Steers, Inc. is a holding company, which operates as an investment manager specializing in liquid real assets, which include real estate securities, listed infrastructure, commodities, natural resource equities, preferred securities, and other income solutions. It manages investment vehicles, such as institutional accounts, open-end funds and closed-end funds. The company was founded by Martin Cohen and Robert Hamilton Steers in 1986 and is headquartered in New York, NY.
Stock Forecast FAQ
In the current month, CNS has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CNS average analyst price target in the past 3 months is $72.00.
-
Where Will Cohen & Steers, Inc. (New York) Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cohen & Steers, Inc. (New York) share price will rise to $72.00 per share over the next 12 months.
-
What Do Analysts Say About Cohen & Steers, Inc. (New York)?
Analysts are divided on their view about Cohen & Steers, Inc. (New York) share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cohen & Steers, Inc. (New York) is a Sell and believe this share price will drop from its current level to $64.00.
-
What Is Cohen & Steers, Inc. (New York)'s Price Target?
The price target for Cohen & Steers, Inc. (New York) over the next 1-year time period is forecast to be $72.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CNS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cohen & Steers, Inc. (New York) is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of CNS?
You can purchase shares of Cohen & Steers, Inc. (New York) via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cohen & Steers, Inc. (New York) shares.
-
What Is The Cohen & Steers, Inc. (New York) Share Price Today?
Cohen & Steers, Inc. (New York) was last trading at $66.11 per share. This represents the most recent stock quote for Cohen & Steers, Inc. (New York). Yesterday, Cohen & Steers, Inc. (New York) closed at $64.83 per share.
-
How To Buy Cohen & Steers, Inc. (New York) Stock Online?
In order to purchase Cohen & Steers, Inc. (New York) stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CNS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CNS
Sector
P/E ratio
21.77x
12.47x
PEG ratio
50.83x
0.32x
P/B ratio
6.01x
1.14x
Price / LTM sales
6.02x
1.87x
Growth Metrics
CNS
Sector
Revenue growth
1.04%
5.49%
Earnings growth
-23.27%
10.49%
Revenue (5-year growth)
6%
8.68%
Earnings forecast
$0.81
$0.64
Profitability
CNS
Sector
Profitability FY 2025
$482.1M
--
Return on invested capital
22.73%
5.2%
Return on assets
19.46%
1.02%
Return on equity
27.14%
9.92%
Earnings Date
Last Earnings Date
Jan
22
Next Earnings Date
Apr
15
Estimated Next Earnings Date
Apr
23
Balance Sheet
CNS
Sector
Total cash
$403.2M
$407.2M
Short term investments
$127M
$192.4M
Total assets
$847.1M
$3.1B
Long term debt
--
$56M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
40
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
91
TDC alert for Feb 12
Teradata Corp. [TDC] is down 10.82% over the past day.
Buy
67
DIOD alert for Feb 12
Diodes, Inc. [DIOD] is down 7.42% over the past day.
Buy
77
VRT alert for Feb 12
Vertiv Holdings Co. [VRT] is down 4.75% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
